I48.19 is a billable ICD-10 code used to specify a medical diagnosis of other persistent atrial fibrillation. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.
The code is commonly used in cardiology medical specialties to specify clinical concepts such as atrial fibrillation and flutter.
The code is linked to some Quality Measures as part of Medicare's Quality Payment Program (QPP). When this code is used as part of a patient's medical record the following Quality Measures might apply: Atrial Fibrillation And Atrial Flutter: Chronic Anticoagulation Therapy.
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Persistent atrial fibrillation
Tabular List of Diseases and Injuries
The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with coding notes and guidance for inclusions, exclusions, descriptions and more. The following references are applicable to this diagnosis code:
Inclusion TermsInclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
- Chronic persistent atrial fibrillation
- Persistent atrial fibrillation, NOS
Index to Diseases and Injuries References
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for this diagnosis code are found in the injuries and diseases index:
I4819 replaces the following previously assigned ICD-10 code(s):
Quality Payment Program Measures
When code I48.19 is part of the patient's diagnoses the following Quality Measures apply and affect reimbursement. The objective of Medicare's Quality Measures is to improve patient care by making it more: effective, safe, efficient, patient-centered and equitable.
|Quality Measure||Description||Quality Domain||Measure Type||High Priority||Submission Methods|
|Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy||Percentage of patients aged 18 years and older with nonvalvular atrial fibrillation (AF) or atrial flutter who were prescribed warfarin OR another FDA-approved oral anticoagulant drug for the prevention of thromboembolism during the measurement period.||Effective Clinical Care||Process||NO||Claims, Registry|
An arrhythmia is a problem with the speed or rhythm of the heartbeat. Atrial fibrillation (AF) is the most common type of arrhythmia. The cause is a disorder in the heart's electrical system.
Often, people who have AF may not even feel symptoms. But you may feel :
- Palpitations -- an abnormal rapid heartbeat
- Shortness of breath
- Weakness or difficulty exercising
- Chest pain
- Dizziness or fainting
AF can lead to an increased risk of stroke. In many patients, it can also cause chest pain, heart attack, or heart failure.
Doctors diagnose AF using family and medical history, a physical exam, and a test called an electrocardiogram (EKG), which looks at the electrical waves your heart makes. Treatments include medicines and procedures to restore normal rhythm.
NIH: National Heart, Lung, and Blood Institute
[Learn More in MedlinePlus]
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020